Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal ‘C-tag’
Jing Jin(Zhejiang Provincial People's Hospital), Simon J. Draper(University of Oxford), Sandra Bezemer(Thermo Fisher Scientific (Netherlands)), Willem A. de Jongh(ExpreS2ion Biotechnologies (Denmark)), Matthew K. Higgins(University of Oxford), Sumi Biswas(University of Oxford), Katherine E. Wright(Memorial Hermann), Pim Hermans(Thermo Fisher Scientific (Netherlands)), Kathryn A. Hjerrild(Research & Development Corporation), Sarah E. Silk(University of Oxford), Aadil El-Turabi(University of Oxford), Alexander D. Douglas(University of Oxford), Frank Detmers(Thermo Fisher Scientific (Netherlands)), Yuanyuan Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Geneviève M. Labbé(University of Oxford), Rebecca Brown(University of Oxford), Rebecca Ashfield(Immunocore (United Kingdom)), Jennifer M. Marshall(University of Oxford), Stine B. Clemmensen(ExpreS2ion Biotechnologies (Denmark))
Cited by 67
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
|Nature Medicine|2020|643
Severe malaria is associated with parasite binding to endothelial protein C receptor
|Nature|2013|579
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
|Scientific Reports|2016|438